Estimated Revenue: $1M to $10M
Last Funding Date: 2022-09-12
Investors Number: 12.0
Industry: End-to-End Drug Development
Funding Status: IPO
Technology: Biotechnology, Health Care, Therapeutics
Employee Number: 101-250
Headquarters: Cambridge, Massachusetts, United States
Last Funding Type: Post-IPO Equity
Total Funding: 1170000000.0
Founded Date: 2016-01-01
Acquisitions Number: 1